The moesin expression, a protein which has been dysregulated in pancreatic cancer and is related to the severity of the illness, rose in response to therapy with a PAD2 isozyme-specific inhibitor, which proved to be most effective in preventing the invasion of Panc-1 cells. This evidence concerns the gene PADI2 and familial pancreatic carcinoma.